Pfizer: Messy Q4 Earnings Mask An Improving Business

On Tuesday morning , Pfizer Inc. ( PFE ) released Q4 and full-year 2025 earnings. The report was solid overall but missed estimates in some respects, causing shares to decline ~5% in the pre-market. The knee-jerk selling was causedBrendan, a Pennsylvanian by birth:-Completed a Ph.D. at Stanford University in the field of organic synthesis (2009). -Worked for a major pharmaceutical company (Merck, 2009-2013).-Worked in biotech including start-ups (Theravance/Aspira) prior to securing employment at Caltech.-F ...